View Clinical Trial (Medical Research Study)


Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID) - NCT00329706-90095(Clinical Trial 143470)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City: Los Angeles
State: CA
Zip Code: 90095
Country: United States
Purpose: A brain PET scan is recognized as "reasonable and necessary" for some patients with "a recently established diagnosis of dementia" (Centers for Medicare and Medicaid Services, Decision Memo CAG-00088R, 2004), but evidence is less clear for patients having less severe cognitive problems. A substantial portion of such patients will develop Alzheimer's disease and other forms of dementia, which affect millions of people in the U.S., costing us over $100 billion annually. This project employs a prospective randomized protocol to determine whether PET scanning can help distinguish those patients with early Alzheimer's changes in their brains from those having other causes of cognitive impairment more accurately than is done with current clinical practices alone, and lead to earlier, more effective therapies which extend patients' abilities to think and function independently.
This page is no longer being updated. Please use our search for current trials or visit ClinicalTrials.gov
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.